Ardelyx Inc (ARDX) concluded trading on Wednesday at a closing price of $4.85, with 4.19 million shares of worth about $20.34 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -16.95% during that period and on April 23, 2025 the price saw a gain of about 0.83%. Currently the company’s common shares owned by public are about 238.02M shares, out of which, 230.59M shares are available for trading.
Stock saw a price change of 4.53% in past 5 days and over the past one month there was a price change of -7.62%. Year-to-date (YTD), ARDX shares are showing a performance of -4.34% which decreased to -25.15% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.02 but also hit the highest price of $9.33 during that period. The average intraday trading volume for Ardelyx Inc shares is 4.28 million. The stock is currently trading 3.39% above its 20-day simple moving average (SMA20), while that difference is down -5.53% for SMA50 and it goes to -12.11% lower than SMA200.
Ardelyx Inc (NASDAQ: ARDX) currently have 238.02M outstanding shares and institutions hold larger chunk of about 63.69% of that.
The stock has a current market capitalization of $1.16B and its 3Y-monthly beta is at 0.77. It has posted earnings per share of -$0.17 in the same period. It has Quick Ratio of 4.31 while making debt-to-equity ratio of 0.89. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ARDX, volatility over the week remained 5.66% while standing at 6.58% over the month.
Stock’s fiscal year EPS is expected to drop by -36.07% while it is estimated to increase by 210.40% in next year.
Coverage by BTIG Research stated Ardelyx Inc (ARDX) stock as a Buy in their note to investors on March 04, 2025, suggesting a price target of $14 for the stock. On November 11, 2024, H.C. Wainwright Downgrade their recommendations, while on July 02, 2024, Piper Sandler Downgrade their ratings for the stock with a price target of $7. Stock get an Outperform rating from Leerink Partners on April 05, 2024.
